The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 22, 2020

Filed:

Apr. 06, 2017
Applicant:

Brandeis University, Waltham, MA (US);

Inventors:

Isaac J. Krauss, Waltham, MA (US);

Joel Sebastian Temme, Waltham, MA (US);

Assignee:

BRANDEIS UNIVERSITY, Waltham, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); C07H 21/04 (2006.01); C07K 16/10 (2006.01); A61K 39/395 (2006.01); A61K 48/00 (2006.01); C07H 15/22 (2006.01); C12N 15/115 (2010.01); C12N 15/10 (2006.01); A61P 31/18 (2006.01); A61K 39/39 (2006.01); C12N 15/117 (2010.01);
U.S. Cl.
CPC ...
A61K 39/0005 (2013.01); A61K 39/39 (2013.01); A61P 31/18 (2018.01); C07H 15/22 (2013.01); C07H 21/04 (2013.01); C12N 15/10 (2013.01); C12N 15/115 (2013.01); C12N 15/117 (2013.01); A61K 2039/51 (2013.01); A61K 2039/545 (2013.01); C12N 2310/13 (2013.01); C12N 2310/16 (2013.01); C12N 2310/351 (2013.01); C12N 2320/30 (2013.01);
Abstract

Disclosed are oligonucleotides that binds specifically to HIV neutralizing monoclonal antibody 2G12 with a Kvalue lower than 20 nM, the oligonucleotide comprising a predicted structure, at 37° C., having exactly one stem-loop whereby the loop comprises the nucleotide sequence of AACCACGGAAAA (SEQ ID NO: 1), whereis a modified nucleoside base, and the stem includes at least 3 nucleotide base-pairs and one of the nucleotides in the stem includes a modified nucleoside base, wherein the modified nucleoside base has the structure -B-L-A where A is a branched-chain Manoligosaccharide, L is a linker molecule, and B is independently a pyrimidine or pyridine base linked to the sugar-phosphate backbone of the oligonucleotide. Immunogenic conjugates that include the oligonucleotide, and pharmaceutical compositions that include the oligonucleotide or the immunogenic conjugate are also disclosed. Various method of using the oligonucleotides, immunogenic conjugates, and pharmaceutical compositions are also disclosed.


Find Patent Forward Citations

Loading…